Chronos CEO, Dr Huw Jones has been awarded best CEO in the European drug discovery industry by online and print magazine European CEO. Read the press release.
Dr Schulz-Utermoehl has over 17 years’ experience in the pharmaceutical industry, spanning early and late-stage discovery research and pre-clinical development. He and Dr Fraser Murray will be [...]
Dr Murray brings more than 20 years’ of drug discovery and early development experience across a range of therapeutic areas, including neurodegeneration, psychiatry, inflammation and [...]
Chronos joins Oxford Biodynamics and The Nuffield Department of Clinical Neurosciences, Oxford in search for better diagnosis and prognosis of ALS in a programme valued at £1.26m. Read the press [...]
Chronos Therapeutics Ltd completes major fund raise in an over-subscribed round. Funding will support the acceleration of lead compound into neurodegenerative disease. Read the press release.